title: Protein kinase C inhibitors: a patent review (2008 - 2009).
abstract: BACKGROUND
  The protein kinase C (PKC) is a family of multifunctional isoenzymes involved in apoptosis, migration, adhesion, tumorgenesis, cardiac hypertrophy, angiogenesis, platelet function and inflammation. It also plays a vital role in the regulation of signal transduction, cell proliferation and differentiation through positive and negative regulation of the cell cycle. In this work, we reviewed the existing PKC inhibitors and several patents linked to PKC inhibitors.
  
  
  METHODS
  Thorough survey on the PKC inhibitors having clinical importance and patents filed for these inhibitors from 2008 - 2009 is reported.
  
  
  CONCLUSIONS
  PKCs are highly potential therapeutic targets for treating diabetic complications, oncological, inflammatory, immunological and dermatological disorders. The clinical trial candidates of PKCs mainly target the catalytic domain, which is highly conserved throughout the PKC family making it difficult to target a particular isoform selectively. Relatively less chemical space and fewer bisubstrate inhibitors targeting both ATP and regulatory domain are explored for PKCs, more research in these areas will be helpful in overcoming existing problems.
authors.affiliation: National Institute of Pharmaceutical Education and Research (NIPER), Department of Pharmacoinformatics , Sector 67, SAS Nagar (Mohali), Punjab , India mesophia@niper.ac.in.
authors.forename: M Elizabeth
authors.initials: ME
authors.lastname: Sobhia
authors.forename: Baljinder K
authors.initials: BK
authors.lastname: Grewal
authors.forename: Stanly Paul
authors.initials: SP
authors.lastname: Ml
authors.forename: Jigneshkumar
authors.initials: J
authors.lastname: Patel
authors.forename: Amandeep
authors.initials: A
authors.lastname: Kaur
authors.forename: Thongtinlal
authors.initials: T
authors.lastname: Haokip
authors.forename: Alekhya
authors.initials: A
authors.lastname: Kokkula
mesh_terms: D000818:Animals; D015195:Drug Design; D055808:Drug Discovery; D006801:Humans; D007527:Isoenzymes / Q000037:antagonists & inhibitors; D010330:Patents as Topic; D011493:Protein Kinase C / Q000037:antagonists & inhibitors*; D047428:Protein Kinase Inhibitors / Q000145:classification / Q000494:pharmacology* / Q000627:therapeutic use
chemical_list: D007527:Isoenzymes; D047428:Protein Kinase Inhibitors; D011493:Protein Kinase C